[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Decoy Therapeutics Inc (DCOY)

Decoy Therapeutics Inc (DCOY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,325
  • Shares Outstanding, K 532
  • Annual Sales, $ 0 K
  • Annual Income, $ -12,520 K
  • EBIT $ -13 M
  • EBITDA $ -13 M
  • 60-Month Beta 0.56
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.91

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year $-80.99
  • Growth Rate Est. (year over year) +1,333.49%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.32 +52.77%
on 05/15/26
9.57 -31.03%
on 06/01/26
+0.88 (+15.38%)
since 05/08/26
3-Month
4.32 +52.77%
on 05/15/26
9.57 -31.03%
on 06/01/26
-2.01 (-23.35%)
since 03/09/26
52-Week
4.32 +52.77%
on 05/15/26
415.80 -98.41%
on 07/29/25
-123.49 (-94.93%)
since 06/09/25

Most Recent Stories

More News
Decoy Therapeutics' CEO to Participate in hVIVO Capital Markets Day in London

Rick Pierce to join speakers from Boehringer Ingelheim, RA Capital and ILiAD Biotechnologies for discussion on early clinical development

DCOY : 6.00 (-4.00%)
Decoy Therapeutics Nominates Global Biopharma Executive Patricia Gauthier for Election to Board of Directors

CAMBRIDGE, Mass. , June 3, 2026 /PRNewswire/ -- Decoy Therapeutics Inc. (Nasdaq: DCOY), a biotechnology company pioneering Designable Multi-Antivirals (D-MAVs™), a new category of antivirals engineered...

DCOY : 6.00 (-4.00%)
Decoy Therapeutics Partners with hVIVO to Advance Lead D-MAVâ„¢ Candidate into the Clinic

Collaboration supports Phase 1 and Phase 2a human proof-of-concept studies for new antiviral category designed to address multiple viruses with a single adaptable therapeutic

DCOY : 6.00 (-4.00%)
Decoy Therapeutics Names Brad Pentelute, MIT Professor of Chemistry, as Chair of Scientific Advisory Board

Appointment deepens scientific leadership as Decoy advances its Designable Multi-Antiviral pipeline toward clinical development

DCOY : 6.00 (-4.00%)
Decoy Therapeutics: Q1 Earnings Snapshot

Decoy Therapeutics: Q1 Earnings Snapshot

DCOY : 6.00 (-4.00%)
Decoy Therapeutics to Present at Two Peptide Therapeutics Conferences in Boston

CBO Peter Marschel to Lead HubXchange Roundtable on Computational Peptide Design

DCOY : 6.00 (-4.00%)
Decoy Therapeutics Builds Momentum with Accelerating Execution, Entering a Highly Catalytic Phase with a Clearly Defined Path to Clinical Development of its Antiviral Pipeline

Highly differentiated AI-powered D-MAV discovery platform targeting drug discovery in the multi-billion-dollar antiviral markets

DCOY : 6.00 (-4.00%)
Decoy Therapeutics to Participate in Virtual Investor Closing Bell Event Highlighting Business Outlook for 2026

Live video webcast with Rick Pierce, Chief Executive Officer of Decoy Therapeutics, on Thursday, April 9 th at 4:00 PM ET

DCOY : 6.00 (-4.00%)
Decoy Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

CAMBRIDGE, Mass. and HOUSTON , April 2, 2026 /PRNewswire/ -- Decoy Therapeutics, Inc. (Nasdaq: DCOY) (Decoy, or the Company), announces that on March 31, 2026 the Company received notification from...

DCOY : 6.00 (-4.00%)
Decoy Therapeutics Enters Strategic Partnership with Quantori to Deploy Google Cloud-native Integrated AI-Driven Peptide Design and Molecular Simulation Platform

Partnership supported by funding from Google Cloud will increase Decoy's computational peptide design bandwidth by 25-100x

DCOY : 6.00 (-4.00%)

Business Summary

Decoy Therapeutics Inc. is a preclinical-stage biotechnology company which target serious unmet medical needs. The Company's initial pipeline is focused on respiratory viruses and GI cancers. Decoy Therapeutics Inc., formerly known as Salarius Pharmaceuticals Inc., is based in CAMBRIDGE, Mass.

See More

Key Turning Points

3rd Resistance Point 7.51
2nd Resistance Point 7.01
1st Resistance Point 6.63
Last Price 6.00
1st Support Level 5.75
2nd Support Level 5.25
3rd Support Level 4.87

See More

52-Week High 415.80
Fibonacci 61.8% 258.61
Fibonacci 50% 210.06
Fibonacci 38.2% 161.51
Last Price 6.00
52-Week Low 4.32

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.